Uracil
In clinical developmentRecent clinical, regulatory, research and industry developments relating to this drug.
Thyroid hormone and the Liver.
The first MASH drug therapy on the horizon: Current perspectives of resmetirom.
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Diabetes, obesity & metabolism1
- Hepatology communications1
- Journal of hepatology1
- Journal of the American College of Cardiology1
- Liver international : official journal of the International Association for the Study of the Liver1
- Metabolism: clinical and experimental1
- Targher G2
- Abraham TP1
- Aghemo A1
- Amellal N1
- Benhadji KA1
- Bondarenko I1
- Boutari C1
- Bruinstroop E1
- Oregon Health and Science University2
- University of Verona2
- Beth Israel Deaconess Medical Center1
- Biological Resource Center Unit1
- Boston University Chobanian & Avedisian School of Medicine1
- Brigham and Women's Hospital1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 5 of the same disease areas as Uracil in the shared literature.
Studied across 3 of the same disease areas as Uracil in the shared literature.
Studied across 3 of the same disease areas as Uracil in the shared literature.
Studied across 3 of the same disease areas as Uracil in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials